Tokyo, Jan. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060291) titled 'Utility of Interstitial Pneumonia Biomarkers in the Differential Diagnosis of Immune Checkpoint Inhibitor-Related Pneumonitis' on Jan. 7.
Study Type:
Observational
Primary Sponsor:
Institute - Hamamatsu University School of Medicine
Condition:
Condition - Immune checkpoint inhibitor-related pneumonitis and other newly developed acute pulmonary diseases in cancer patients
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the utility of KL-6 and SP-D in the differential diagnosis between immune checkpoint inhibitor-related pneumonitis and other pulmonar...